Table 3. The prognostic values of UA as continuous or categorical variable for cardiovascular mortality.
Subjects | Age, gender-adjusted in Model 1 | Multivariate-adjusted in Model 2 | Multivariate-adjusted in Model 3 | |||
Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | Hazard ratio (95% CI) | P | |
UA (per 1 mg/dL increase) | 1.12(1.05, 1.20) | 0.001 | 1.05(0.95, 1.17) | 0.35 | 1.04(0.89, 1.20) | 0.65 |
Gender-specific tertiles of UA | ||||||
Tertile 1 | Reference | Reference | Reference | |||
Tertile 2 | 1.56(1.13, 2.15) | 0.007 | 1.48(0.96, 2.29) | 0.08 | 1.29(0.75, 2.23) | 0.35 |
Tertile 3 | 1.69(1.21, 2.38) | 0.002 | 1.50(0.93, 2.41) | 0.09 | 1.35(0.74, 2.46) | 0.33 |
Abbreviation: UA, uric acid; CI, confidence interval.
Model 1: Age, center size-adjusted, gender-adjusted only UA as continuous variable.
Model 2: Age, residual renal function, serum albumin, hemoglobin,phosphate, C-reactive protein and center size-adjusted, gender-adjusted only UA as continuous variable.
Model 3: Age, residual renal function, serum albumin, hemoglobin,phosphate, C-reactive protein, the history of cardiovascular disease, diabetes, body mass index, mean arterial pressure, LDL cholestrol and center size-adjusted, gender-adjusted only UA as continuous variable.